Express Pharma

There has been a strong wave of M&A activity in Indian domestic formulations space

Analysing the increased M&A and investment activity across India’s API, formulations and nutraceutical ingredients, driven by domestic consolidation and inbound global investor interest, Subhakanta Bal, MD, Rothschild & Co tells Viveka Roychowdhury that he is highly confident to grow meaningfully in the next two to three years